Total Valuation
Wai Chun Bio-Technology Ltd. has a market cap or net worth of HK$165.25M. The enterprise value is HK$198.91.
Market CapHK$165.25M
Enterprise ValueHK$198.91
Share Statistics
Wai Chun Bio-Technology Ltd. has 384,309,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding384,309,780
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Wai Chun Bio-Technology Ltd.’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 16.46%.
Return on Equity (ROE)0.16
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)16.46%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee6.18M
Profits Per Employee-239.72K
Employee Count61
Asset Turnover1.76
Inventory Turnover6.04
Valuation Ratios
The current PE Ratio of Wai Chun Bio-Technology Ltd. is ―. Wai Chun Bio-Technology Ltd.’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.06
PB Ratio-0.26
Price to Fair Value-0.26
Price to FCF-0.89
Price to Operating Cash Flow3.60
PEG Ratio0.02
Income Statement
In the last 12 months, Wai Chun Bio-Technology Ltd. had revenue of 377.17M and earned -14.62M in profits. Earnings per share was -0.08.
Revenue377.17M
Gross Profit36.00M
Operating Income5.36M
Pretax Income-8.93M
Net Income-14.62M
EBITDA17.90M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 21.33M and capital expenditures -26.01M, giving a free cash flow of -4.68M billion.
Operating Cash Flow21.33M
Free Cash Flow-4.68M
Free Cash Flow per Share-0.01
Dividends & Yields
Wai Chun Bio-Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.13
52-Week Price Change152.94%
50-Day Moving Average0.43
200-Day Moving Average0.43
Relative Strength Index (RSI)51.44
Average Volume (3m)231.77K
Important Dates
Wai Chun Bio-Technology Ltd. upcoming earnings date is Feb 26, 2027, TBA (Confirmed).
Last Earnings DateSep 25, 2026
Next Earnings DateFeb 26, 2027
Ex-Dividend Date―
Financial Position
Wai Chun Bio-Technology Ltd. as a current ratio of 0.39, with Debt / Equity ratio of -216.98%
Current Ratio0.39
Quick Ratio0.18
Debt to Market Cap3.98
Net Debt to EBITDA4.95
Interest Coverage Ratio0.39
Taxes
In the past 12 months, Wai Chun Bio-Technology Ltd. has paid 1.77M in taxes.
Income Tax1.77M
Effective Tax Rate-0.20
Enterprise Valuation
Wai Chun Bio-Technology Ltd. EV to EBITDA ratio is 6.29, with an EV/FCF ratio of -4.16.
EV to Sales0.30
EV to EBITDA6.29
EV to Free Cash Flow-4.16
EV to Operating Cash Flow-110.80
Balance Sheet
Wai Chun Bio-Technology Ltd. has HK$5.61M in cash and marketable securities with HK$138.35M in debt, giving a net cash position of -HK$132.74M billion.
Cash & Marketable SecuritiesHK$5.61M
Total DebtHK$138.35M
Net Cash-HK$132.74M
Net Cash Per Share-HK$0.35
Tangible Book Value Per Share-HK$0.36
Margins
Gross margin is 8.89%, with operating margin of 1.42%, and net profit margin of -3.88%.
Gross Margin8.89%
Operating Margin1.42%
Pretax Margin-2.37%
Net Profit Margin-3.88%
EBITDA Margin4.75%
EBIT Margin1.25%
Analyst Forecast
The average price target for Wai Chun Bio-Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast66.75%
EPS Growth Forecast87.02%